Biological Soft X-ray Tomography at the Advanced Light Source
Project Number1P30GM138441-01
Contact PI/Project LeaderLARABELL, CAROLYN A
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
Project Summary/Abstract
The National Center for X-ray Tomography (NCXT) provides biomedical researchers with access to unique
technologies for visualizing and quantifying intact, fully hydrated cells in 3D. The NCXT designed, built, and
now operates a soft x-ray microscope (XM-2) at the Advanced Light Source, Berkeley. XM-2 is currently the
only microscope of its kind in the Nation.
The unique characteristics of soft x-rays make them an excellent illumination source in a microscope designed
to images cells. Soft x-rays penetrate large cells easily, allowing researchers to image mammalian cells in great
detail. Moreover, soft x-rays produce image contrast without the need to use stains or other contrast agents;
procedures that could damage the delicate sub-cellular structures and organization. XM-2 is equipped with a
cryogenic specimen stage that can rotate freely through 360 degrees, allowing the specimen to be imaged from
different perspectives. The specimen stage allows researchers to image cells by tomographic methods. In
tomography 2D images are taken from many different perspectives. The resultant `stack' of projection images
is used to calculate a 3D reconstruction of the specimen. In effect, we following the same principles as used in
clinical Computed Tomography (CT), but on individual cells rather than a whole body.
This funding will support the day-to-day maintenance, upgrades, and user operation of XM-2, together with
associated specimen preparation laboratories and ongoing upgrades to our software/computing resources.
This support will ensure biomedical researchers have access to a unique cell imaging technology. During the
funding cycle, we will achieve the following specific aims:
Aim 1: Enable user access to biological soft x-ray tomography (SXT) at the ALS. The work of this aim will
ensure users can bring cells to NCXT and leave with soft x-ray tomographic reconstructions of their specimens.
Significant consideration will be striving to make the Resource as user-friendly as possible, and therefore
accessible to the broadest possible research community as possible, not just to imaging specialists.
Aim 2: Maintain and calibrate XM-2, the NCXT operated soft x-ray microscope at the ALS. As with all
synchrotron beamlines, XM-2 is a sophisticated instrument that requires regular maintenance and calibration.
We will take a programmatic approach to ensure XM-2 is robust, reliable, and operates with minimum
unscheduled downtime.
Aim 3: Implement upgrades and enhancements to ensure the NCXT remains `state-of-the-art.' Over the
timescale of the funding cycles, new hardware, software, and algorithms will become available, and some
existing components will reach their end-of-life. We will, therefore, carry out upgrades and enhancements to
maintain the NCXT at the `state-of-the-art.'
Public Health Relevance Statement
Project Narrative
Soft x-ray tomography can visualize and quantify cell size, shape, and sub cellular organization in intact,
native state cells, in 3D. Soft x-ray tomography can image human cells, parasites and other disease
causing-agents, and organisms that act as models for human disease. Under this funding, we will make
soft x-ray tomography available to a broad range of biomedical researchers to generate insights into our
understanding of neurodegenerative diseases, metastatic cancer, and diabetes, and to accelerate the
development of new therapeutic cures.
No Sub Projects information available for 1P30GM138441-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P30GM138441-01
Patents
No Patents information available for 1P30GM138441-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P30GM138441-01
Clinical Studies
No Clinical Studies information available for 1P30GM138441-01
News and More
Related News Releases
No news release information available for 1P30GM138441-01
History
No Historical information available for 1P30GM138441-01
Similar Projects
No Similar Projects information available for 1P30GM138441-01